Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder

PTSD Clinical Trial

Official title:

Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01652430
• Other study ID #: 10-0159
• Status: Completed
• Phase: N/A
• First received: December 9, 2011
• Last updated: January 6, 2015
• Start date: October 2010
• Est. completion date: July 2013

Study information

• Verified date: July 2012
• Source: VA Eastern Colorado Health Care System
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

This study plans to examine if symptoms of PTSD affect how Veterans who have served in combat think and react to certain information, and whether or not this has an influence on suicidal thoughts.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 78
• Est. completion date: July 2013
• Est. primary completion date: July 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

1. History of combat service

2. Diagnosis of PTSD confirmed by the CAPS or

3. No current diagnosis of PTSD

4. Age 18-65

Exclusion Criteria:

1. Inability to adequately respond to questions regarding the informed consent procedure.

2. History of significant neurological disease

3. Diagnosis of Schizophrenia or other Psychosis

4. Alcohol abuse/dependence or illicit drug use in the two weeks prior to testing

5. No history of combat service

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• PTSD
• Stress Disorders, Post-Traumatic
• Stress Disorders, Traumatic
• Suicidal Ideation

Locations

Country	Name	City	State
United States	Denver VA Medical Center	Denver	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
VA Eastern Colorado Health Care System

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Beck Scale for Suicidal ideation		One time	Yes